Liminatus Pharma Warrants Other Current Assets

The latest other current assets for LIMNW is $46K as of March 2022. That compares with $440K in the prior-year period — down 89.6% year over year. Investors often review this figure alongside Liminatus Pharma Warrants's historical trend and sector peers before judging valuation or financial health.

Over the past year, LIMNW's other current assets moved from $440K to $46K — a 89.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Liminatus Pharma Warrants's operating scale or balance-sheet position.

A other current assets figure of $46K for LIMNW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting LIMNW's other current assets ($46K), review year-over-year change from $440K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.